ACHV Achieve Life Sciences Inc.

Price (delayed)

$5.52

Market cap

$566.68M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.1

Enterprise value

$553.55M

?
Relative Growth: Rel. Growth: 14
Relative Strength: Rel. Strength: 83
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 3

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company ...

Highlights
Achieve Life Sciences's EPS has increased by 18% YoY and by 12% QoQ
Achieve Life Sciences's equity has shrunk by 50% QoQ but it has increased by 3.9% YoY
ACHV's net income is down by 13% YoY but it is up by 4.9% QoQ
The debt has soared by 50% YoY
The quick ratio fell by 38% QoQ and by 24% YoY

Key stats

What are the main financial stats of ACHV

ACHV stock price

How has the Achieve Life Sciences stock price performed over time
Intraday
-4%
1 week
4.35%
1 month
-1.25%
1 year
54.62%
YTD
11.07%
QTD
87.76%

Financial performance

How have Achieve Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$52.45M
Net income
-$51.99M
Gross margin
N/A
Net margin
N/A
Achieve Life Sciences's operating income has decreased by 14% YoY but it has increased by 4.4% QoQ
ACHV's net income is down by 13% YoY but it is up by 4.9% QoQ

Price vs fundamentals

How does ACHV's price correlate with its fundamentals

Growth

What is Achieve Life Sciences's growth rate over time

Valuation

What is Achieve Life Sciences stock price valuation
P/E
N/A
P/B
27.52
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Achieve Life Sciences's EPS has increased by 18% YoY and by 12% QoQ
Achieve Life Sciences's equity has shrunk by 50% QoQ but it has increased by 3.9% YoY
The P/B is 26% more than the 5-year quarterly average of 21.8

Efficiency

How efficient is Achieve Life Sciences business performance
Achieve Life Sciences's return on invested capital has shrunk by 171% YoY and by 10% QoQ
Achieve Life Sciences's return on equity has decreased by 10% YoY but it has increased by 5% QoQ
ACHV's ROA is down by 8% year-on-year but it is up by 8% since the previous quarter

Dividends

What is ACHV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACHV.

Financial health

How did Achieve Life Sciences financials performed over time
The total assets is 48% more than the total liabilities
ACHV's current ratio is down by 40% since the previous quarter and by 25% year-on-year
The quick ratio fell by 38% QoQ and by 24% YoY
The debt is 40% more than the equity
Achieve Life Sciences's debt to equity has soared by 103% from the previous quarter and by 44% YoY
The debt has soared by 50% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.